Patents Assigned to SmithKline Beecham s.a.
  • Pharmaceutical formulations comprising amoxycillin and clavulanate
    Publication number: 20030124187
    Abstract: Novel coamoxiclav formulations are described, having reduced weight compared to existing formulations, as well as formulations comprising amoxycillin and potassium clavulanate in a ratio of 8:1 and formulations prepared from granulates of amoxycillin and granulates of amoxycillin and clavulanate.
    Type: Application
    Filed: November 22, 2002
    Publication date: July 3, 2003
    Applicants: SmithKline Beecham Laboratoires Pharmaceutiques,, SmithKline Beecham s.a., SmithKline Beecham Corporation
    Inventors: Jacky Andre Gustave Mention, Jose Luis Sanroma Bordallo, Kevin Huntley Storm
  • Formulation
    Publication number: 20020065263
    Abstract: A new parenteral dosage form for 7-D-mandelamido-3-(1-sulfomethyltetrazol-5-yl)thiomethyl) -3-cephem-4-carboxylic acid mono sodium salt (“Cefonicid”) is provided.
    Type: Application
    Filed: November 30, 2001
    Publication date: May 30, 2002
    Applicant: SmithKline Beecham S.A.
    Inventors: Africa Aranda Garcia, Fernando Hijar Ordovas
  • Fusion glycoprotein from HCMV and HSV
    Patent number: 5889168
    Abstract: A nucleic acid comprising a sequence encoding a fusion protein comprising a portion of the glycoprotein B of HCMV fused to a portion of the glycoprotein D of HSV-2.
    Type: Grant
    Filed: November 18, 1996
    Date of Patent: March 30, 1999
    Assignee: SmithKline Beecham s.a.
    Inventor: Dirk Richard Gheysen